BackDoximity Overview
Doximity Inc - Ordinary Shares - Class A

Doximity Target Price

Analysts' average 12-month price target for Doximity is $27.

Get informed when a big investor buys or sells

+ Follow

Share Price

$25.14

Average Target Price

$26.897% upside

18 analysts in the last 4 months

High: $41 | Low: $18

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-13Truist FinancialJailendra Singh$244.5% downsideOpen
2026-08-07NeedhamScott Berg$4163.1% upsideOpen
2026-08-07Evercore ISIElizabeth Anderson$4059.1% upsideOpen
2026-08-07BMO Capital$3019.3% upsideOpen
2026-08-07Canaccord Genuity$3643.2% upsideOpen
2026-05-14Barclays$2020.4% downsideOpen
2026-05-14Truist FinancialJailendra Singh$1924.4% downsideOpen
2026-05-14BMO CapitalSean Dodge$2020.4% downsideOpen
2026-05-14NeedhamScott Berg$277.4% upsideOpen
2026-05-14Mizuho Securities$263.4% upsideOpen
2026-05-14Canaccord Genuity$3019.3% upsideOpen
2026-05-14Goldman Sachs$244.5% downsideOpen
2026-05-14Morgan StanleyCraig Hettenbach$3539.2% upsideOpen
2026-05-14Leerink PartnersMichael Cherny$250.6% downsideOpen
2026-05-14Wells Fargo$1828.4% downsideOpen
2026-05-14Jefferies$1924.4% downsideOpen
2026-05-14Robert W. BairdVikram Kesavabhotla$1828.4% downsideOpen
2026-05-11Wells Fargo$3227.3% upsideOpen
2026-04-20Truist Financial$2915.4% upsideOpen
2026-03-17Loop Capital MarketsGene Mannheimer$3123.3% upsideOpen
2026-02-20Piper Sandler$4267.1% upsideOpen
2026-02-09Canaccord GenuityRichard Close$3435.2% upsideOpen
2026-02-06KeyBanc$3851.2% upsideOpen
2026-02-06Truist FinancialJailendra Singh$3747.2% upsideOpen
2026-02-06Goldman Sachs$3435.2% upsideOpen
2026-02-06Morgan Stanley$4994.9% upsideOpen
2026-02-06BMO Capital$250.6% downsideOpen
2026-02-06BTIGDavid Larsen$5098.9% upsideOpen
2026-02-06NeedhamScott Berg$55118.8% upsideOpen
2026-02-06Piper SandlerJessica Tassan$4059.1% upsideOpen
2026-02-06Wells Fargo$4579% upsideOpen
2026-02-04Mizuho Securities$4579% upsideOpen
2026-01-20Wells FargoStan Berenshteyn$55118.8% upsideOpen
2026-01-09Goldman SachsDavid Roman$4994.9% upsideOpen
2026-01-08RBC Capital$59134.7% upsideOpen
2026-01-08Truist FinancialJailendra Singh$62146.6% upsideOpen
2026-01-08KeyBanc$60138.7% upsideOpen
2026-01-08Canaccord GenuityRichard Close$4890.9% upsideOpen
2026-01-08Canaccord Genuity$5098.9% upsideOpen
2025-12-15Morgan Stanley$65158.6% upsideOpen
2025-12-08BarclaysGlen Santangelo$63150.6% upsideOpen
2025-10-08Evercore ISI$81222.2% upsideOpen
2025-10-08KeyBancScott Schoenhaus$80218.2% upsideOpen
2025-10-01Goldman SachsDavid Roman$64154.6% upsideOpen
2025-09-18Canaccord GenuityRichard Close$67166.5% upsideOpen
2025-09-10Raymond James$75198.3% upsideOpen
2025-05-20Goldman SachsDavid Roman$5098.9% upsideOpen
2025-05-16Truist FinancialJailendra Singh$52106.8% upsideOpen
2025-05-16Raymond JamesBrian Peterson$65158.6% upsideOpen
2025-01-13Wells FargoStan Berenshteyn$4371% upsideOpen

Doximity (DOCS) FAQ

As of the most recent data, DOCS shows a target price of $27. Scroll down for historical charts and peer comparison views.

If Doximity moved to the average analyst target of $27, shares would be roughly 7.0% higher than $25.14. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Doximity's earnings trajectory.

Besides this target price page, Stockcircle has Doximity's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $27) with ownership activity and broader fundamentals.

Doximity's target price is $27; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.